Factors Associated With Underestimation of Invasive Cancer in Patients With Ductal Carcinoma In Situ | Zendy

Carlos Chavez de Paz Villanueva | Zendy; Valentina Bonev | Zendy; Maheswari Senthil | Zendy; Naveenraj L. Solomon | Zendy; Mark E. Reeves | Zendy; Carlos A. Garberoglio | Zendy; Jukes P. Namm | Zendy; Sharon S. Lum | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Factors Associated With Underestimation of Invasive Cancer in Patients With Ductal Carcinoma In Situ

Author(s) -

Carlos Chavez de Paz Villanueva,

Valentina Bonev,

Maheswari Senthil,

Naveenraj L. Solomon,

Mark E. Reeves,

Carlos A. Garberoglio,

Jukes P. Namm,

Sharon S. Lum

Publication year - 2017

Publication title -

jama surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.757

H-Index - 176

eISSN - 2168-6262

pISSN - 2168-6254

DOI - 10.1001/jamasurg.2017.2181

Subject(s) - medicine , overdiagnosis , ductal carcinoma , cancer , retrospective cohort study , carcinoma , breast cancer , cohort , cancer registry , oncology , radiology

Recent recognition of the overdiagnosis and overtreatment of ductal carcinoma in situ (DCIS) detected by mammography has led to the development of clinical trials randomizing women with non-high-grade DCIS to active surveillance, defined as imaging surveillance with or without endocrine therapy, vs standard surgical care.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research